Diabetic Supplies / CGM
See also Blood Glucose Monitor / CGM Devices
Test strips, sensors, and devices for blood/glucose monitoring; typically covered with specific dollar or frequency limits.
How It Works
A standard blood glucose monitor needs a small finger-prick blood sample to give a reading, while a continuous glucose monitoring (CGM) system uses a small sensor worn on the body, often on the stomach or arm, that tests sugar levels every few minutes and sends the information to an attached transmitter and then to a receiver such as a compatible mobile device, insulin pump, or standalone reader. In Canada there are three main approaches: capillary blood glucose monitoring using a finger-prick drop of blood, intermittently-scanned continuous glucose monitoring (also called flash glucose monitoring), and real-time continuous glucose monitoring. Most health insurance plans classify these monitors and CGM devices as eligible medical equipment or diabetic supplies, and coverage usually includes reimbursement for the purchase or replacement of monitors and sensors along with accessories such as test strips, lancets, and transmitters.
Example:
Imagine a Canadian living with type 1 diabetes who has a workplace extended health plan that treats CGM systems as diabetic supplies. The plan reimburses a portion of eligible sensor and transmitter costs up to an annual maximum, but only after the member submits a physician's prescription for pre-authorization. Because the member lives in British Columbia, they may also apply for public CGM coverage through PharmaCare Special Authority. If approved, the public plan can cover the device first and the private plan helps with the remaining eligible amounts, subject to the plan's replacement-frequency and reasonable-and-customary limits.
What to Watch For:
Coverage for diabetic-supply benefits may be limited by an annual cap, a reasonable and customary price limit, or a replacement frequency such as one monitor every five years, and some insurers require a physician's prescription or pre-authorization before they reimburse. Public coverage of glucose monitoring devices is inconsistent across Canada, and standard glucometers are typically not covered under public plans, though some specialty glucometers may be reimbursed through private insurance. Because Canada's universal healthcare generally does not cover prescription drugs outside Quebec, many Canadians with type 1 diabetes rely on private insurance, usually funded by an employer, union, or association through a pooled healthcare plan, to access glucose monitoring devices, insulin pumps, and insulin. While roughly 85% of insurance providers in Canada offer CGM and flash glucose monitoring coverage on most of their plans, some benefit plans will not cover devices a doctor has deemed medically necessary unless the plan includes extended or enhanced benefits.
